Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

285
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
285
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

181
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
181
Depression: Overview01:18

Depression: Overview

294
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
294
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

147
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
147
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

614
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
614
Cognitive Therapy01:25

Cognitive Therapy

185
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
185

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of a web-based behavioural activation intervention for individuals with depression based on the Health Action Process Approach: protocol for a randomised controlled trial with a 6-month follow-up.

BMJ open·2022
Same author

Effectiveness of a psychological online training to promote physical activity among students: protocol of a randomized-controlled trial.

Trials·2021
Same author

Quality of Physical Activity Apps: Systematic Search in App Stores and Content Analysis.

JMIR mHealth and uHealth·2021
Same author

Supporting patient adherence to physical activity and exercise: evaluation of a behavior change counseling training program for physiotherapists.

Physiotherapy theory and practice·2021
Same author

The proteasome: friend and foe of mitochondrial biogenesis.

FEBS letters·2020
Same author

Correction: A Web-Based Acceptance-Facilitating Intervention for Identifying Patients' Acceptance, Uptake, and Adherence of Internet- and Mobile-Based Pain Interventions: Randomized Controlled Trial.

Journal of medical Internet research·2019

Related Experiment Video

Updated: Jul 29, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.6K

Internet-Based Behavioral Activation for Depression: Systematic Review and Meta-Analysis.

Carolin Sophie Alber1, Lena Violetta Krämer1, Sophia Marie Rosar1

  • 1Department of Rehabilitation Psychology and Psychotherapy, Institute of Psychology, University of Freiburg, Freiburg, Germany.

Journal of Medical Internet Research
|May 25, 2023
PubMed
Summary

Internet-based behavioral activation (iBA) effectively reduces depressive symptoms posttreatment. While not sustained at 6-month follow-up, iBA also improved anxiety and quality of life.

Keywords:
behavioral activationdepressioninternet- and mobile-based interventionmeta-analysissystematic review

More Related Videos

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.0K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K

Related Experiment Videos

Last Updated: Jul 29, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.6K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.0K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K

Area of Science:

  • Psychiatry and Behavioral Science
  • Digital Health
  • Evidence-Based Medicine

Background:

  • Depression is a global health concern, necessitating accessible treatment options.
  • Internet-based behavioral activation (iBA) offers a scalable solution to enhance treatment accessibility.
  • This study systematically reviewed the efficacy of iBA for depression.

Approach:

  • A comprehensive systematic search of multiple databases (MEDLINE, PsycINFO, PSYNDEX, CENTRAL) was conducted up to December 2021.
  • Included were 12 randomized controlled trials (RCTs) involving 3274 participants with depressive symptoms.
  • Data were synthesized using random-effects meta-analyses, adhering to PRISMA guidelines.

Key Points:

  • iBA significantly reduced self-reported depressive symptom severity posttreatment compared to inactive controls (SMD -0.49, P<.001).
  • Improvements were observed in anxiety reduction, quality of life, and activation levels.
  • No significant effects on depressive symptoms were found at 6-month follow-up; heterogeneity was moderate to substantial (I²=53%).

Conclusions:

  • Internet-based behavioral activation is an effective intervention for reducing depressive symptoms.
  • iBA shows promise as a treatment option, particularly where traditional services are limited.
  • Further research may explore long-term efficacy and optimal delivery methods.